Leukemia and Lymphoma Awareness Month

Leukemia and Lymphoma Awareness Month is observed throughout September to raise awareness of blood cancers that affect the body’s blood-forming tissues and immune system. The observance highlights leukemia, lymphoma, and related conditions while helping the public better understand their symptoms, risk factors, treatment options, and the importance of medical research.

Throughout the month, people are encouraged to learn more, support patients and families, honor those who have been affected, and recognize the dedication of healthcare professionals and researchers. It is also an opportunity to promote compassion, encourage conversations about health, and support organizations working to improve diagnosis, treatment, and outcomes for people living with blood cancers.

Leukemia and Lymphoma Awareness Month is observed throughout September to increase public understanding of leukemia, lymphoma, and related blood cancers. Its roots lie in the growth of patient-support and cancer-advocacy organizations during the twentieth century, particularly the Leukemia & Lymphoma Society (LLS), which was founded in 1949. Organizations such as LLS helped bring greater attention to diseases that were once poorly understood, while also supporting research, patient services, and efforts to improve access to treatment.

The observance developed alongside major advances in hematology and oncology. Improvements in diagnostic testing, chemotherapy, radiation therapy, stem-cell transplantation, targeted medicines, and immunotherapies have changed the outlook for many patients. Awareness efforts have helped communicate these developments to the public while emphasizing that leukemia and lymphoma are not single diseases: they include multiple forms with different symptoms, courses, and treatments. Public education also encourages people to discuss persistent or unusual symptoms with health professionals and to learn about clinical trials and available support.

Over time, the month has become a platform for fundraising, advocacy, remembrance, and community participation. Hospitals, nonprofit organizations, researchers, schools, workplaces, and families may use September to share educational materials, honor people affected by blood cancers, promote blood or stem-cell donation, and raise money for research and patient assistance. These activities reflect the important role of survivors and caregivers, whose experiences have helped shape research priorities and public policy.

Culturally, Leukemia and Lymphoma Awareness Month gives visibility to illnesses that can be less familiar to the general public than some solid tumors. It connects scientific progress with personal stories, recognizing both the grief caused by blood cancers and the hope created by better diagnosis and treatment. By bringing together patients, families, medical professionals, advocates, and donors throughout September, the observance continues the long-standing work of turning awareness into support, research funding, and improved outcomes.